Azitra, Inc. (AZTR)
$0.12-7.69%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1M
- Beta
- -1.04
- P/E (TTM)
- -0.10
- Short % float
- 2.36%
- Days to cover
- 1.0
- SI change
- -65.7%
- 1W
- -14.29%
- 1M
- -33.33%
- vs SPY 1W
- -14.71%
- vs SPY 1M
- -35.39%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on AZTR?
- LOPJLB’s latest quantitative signal on Azitra, Inc. (AZTR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AZTR in?
- Azitra, Inc. (AZTR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Azitra, Inc. (AZTR) do?
- Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features several key therapeutic candidates: ATR-12: A genetically modified strain of S. epidermidis intended to treat Netherton sy…